These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 30782263)

  • 21. Evaluation of Teicoplanin Trough Values After the Recommended Loading Dose in Children With Associated Safety Analysis.
    Yamada T; Kubota T; Yonezawa M; Nishio H; Kanno S; Yano T; Kobayashi D; Egashira N; Takada H; Hara T; Masuda S
    Pediatr Infect Dis J; 2017 Apr; 36(4):398-400. PubMed ID: 27977550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retrospective study of teicoplanin loading regimen that rapidly achieves target 15-30 μg/mL serum trough concentration.
    Kato H; Hamada Y; Hagihara M; Hirai J; Nishiyama N; Koizumi Y; Yamagishi Y; Matsuura K; Mikamo H
    J Infect Chemother; 2016 May; 22(5):308-13. PubMed ID: 26960579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of vancomycin and teicoplanin trough serum levels in patients with infected orthopedic devices: new data for old therapies.
    Lemaire X; Loiez C; Valette M; Migaud H; Dubreuil L; Yazdanpanah Y; Senneville E
    J Infect Chemother; 2011 Jun; 17(3):370-4. PubMed ID: 21053041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An assessment of teicoplanin use and monitoring serum levels in a Chinese teaching hospital.
    Dong YL; Dong HY; Hu SS; Wang X; Wei YX; Wang MY; Dong WH; Yao HP; You HS; Xing JF
    Int J Clin Pharmacol Ther; 2011 Jan; 49(1):14-22. PubMed ID: 21176720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Teicoplanin pharmacokinetics during albumin dialysis.
    Weiler S; Falkensammer G; Seger C; Joannidis M; Bellmann R
    Artif Organs; 2011 Oct; 35(10):969-71. PubMed ID: 21501193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased teicoplanin doses are associated with improved serum levels but not drug toxicity.
    Matthews PC; Chue AL; Wyllie D; Barnett A; Isinkaye T; Jefferies L; Lovering A; Scarborough M
    J Infect; 2014 Jan; 68(1):43-9. PubMed ID: 24012820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project.
    Frazee E; Rule AD; Lieske JC; Kashani KB; Barreto JN; Virk A; Kuper PJ; Dierkhising RA; Leung N
    Am J Kidney Dis; 2017 May; 69(5):658-666. PubMed ID: 28131530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single-centre retrospective observational study comparing trough blood concentration and safety of teicoplanin formulations.
    Shinoda R; Shinoda Y; Ohashi K; Matsuoka T; Hirose T; Sugiyama T; Yoshimura T
    J Infect Chemother; 2019 Jul; 25(7):563-566. PubMed ID: 30929977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age- and gender-related differences in teicoplanin levels in paediatric patients.
    Strenger V; Hofer N; Rödl S; Hönigl M; Raggam R; Seidel MG; Dornbusch HJ; Sperl D; Lackner H; Schwinger W; Sovinz P; Benesch M; Urlesberger B; Urban C
    J Antimicrob Chemother; 2013 Oct; 68(10):2318-23. PubMed ID: 23702837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating the optimal dose of teicoplanin with therapeutic drug monitoring: not too high for adverse event, not too low for treatment efficacy.
    Kim SH; Kang CI; Huh K; Cho SY; Chung DR; Lee SY; Kim YJ; Peck KR
    Eur J Clin Microbiol Infect Dis; 2019 Nov; 38(11):2113-2120. PubMed ID: 31372903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic studies of linezolid and teicoplanin in the critically ill.
    Whitehouse T; Cepeda JA; Shulman R; Aarons L; Nalda-Molina R; Tobin C; MacGowan A; Shaw S; Kibbler C; Singer M; Wilson AP
    J Antimicrob Chemother; 2005 Mar; 55(3):333-40. PubMed ID: 15705641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Teicoplanin levels in bone and joint infections: are standard doses subtherapeutic?
    Matthews PC; Taylor A; Byren I; Atkins BL
    J Infect; 2007 Nov; 55(5):408-13. PubMed ID: 17825421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Higher Teicoplanin Blood Level Needed in Elderly Critically Ill Patients.
    Wang L; Chen M; Ye H; Lin X; Li Y; Ruan J; Lin F; Lin Y
    Curr Drug Metab; 2021; 22(14):1124-1131. PubMed ID: 34809542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance of a divided-load intravenous vancomycin dosing strategy for critically ill patients.
    Denetclaw TH; Dowling TC; Steinke D
    Ann Pharmacother; 2013 Dec; 47(12):1611-7. PubMed ID: 24259632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Change of teicoplanin loading dose requirement for incremental increases of systemic inflammatory response syndrome score in the setting of sepsis.
    Nakano T; Nakamura Y; Takata T; Irie K; Sano K; Imakyure O; Mishima K; Futagami K
    Int J Clin Pharm; 2016 Aug; 38(4):908-14. PubMed ID: 27125378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Teicoplanin therapeutic drug monitoring in critically ill patients: a retrospective study emphasizing the importance of a loading dose.
    Pea F; Brollo L; Viale P; Pavan F; Furlanut M
    J Antimicrob Chemother; 2003 Apr; 51(4):971-5. PubMed ID: 12654757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of meropenem in critically ill patients with severe infections.
    Binder L; Schwörer H; Hoppe S; Streit F; Neumann S; Beckmann A; Wachter R; Oellerich M; Walson PD
    Ther Drug Monit; 2013 Feb; 35(1):63-70. PubMed ID: 23318279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simplified dosing regimens of teicoplanin for patient groups stratified by renal function and weight using Monte Carlo simulation.
    Yamada T; Nonaka T; Yano T; Kubota T; Egashira N; Kawashiri T; Oishi R
    Int J Antimicrob Agents; 2012 Oct; 40(4):344-8. PubMed ID: 22818770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tolerability and Plasma Drug Level Monitoring of Prolonged Subcutaneous Teicoplanin Treatment for Bone and Joint Infections.
    El Samad Y; Lanoix JP; Bennis Y; Diouf M; Saroufim C; Brunschweiler B; Rousseau F; Joseph C; Hamdad F; Ait Amer Meziane M; Routier S; Schmit JL
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6365-8. PubMed ID: 27458228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of teicoplanin concentrations and safety analysis in neonates.
    Yamada T; Kubota T; Nakamura M; Ochiai M; Yonezawa M; Yano T; Kawashiri T; Egashira N; Hara T; Masuda S
    Int J Antimicrob Agents; 2014 Nov; 44(5):458-62. PubMed ID: 25218156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.